The ALS2 gene amyotrophic lateral sclerosis type 2 juvenile genetic test is a specialized diagnostic tool aimed at identifying mutations in the ALS2 gene, which are linked to the development of juvenile amyotrophic lateral sclerosis (ALS) type 2. This form of ALS is an inherited neurodegenerative disorder that affects motor neurons, leading to progressive muscle weakness and atrophy. The onset of symptoms typically occurs in childhood or adolescence, making early diagnosis crucial for managing the condition and planning appropriate care.
DNA Labs UAE offers this genetic test, providing a comprehensive analysis of the ALS2 gene to detect mutations that could indicate a predisposition to developing ALS type 2. The test is performed using a sample of the patient's blood or saliva, which is then analyzed using advanced genetic sequencing techniques to identify any genetic alterations.
The cost of the ALS2 gene amyotrophic lateral sclerosis type 2 juvenile genetic test at DNA Labs UAE is 4400 AED. This price reflects the intricate nature of genetic testing and the specialized expertise required to accurately interpret the results. Individuals considering this test are often those with a family history of ALS type 2 or early signs of the disease, aiming to confirm a diagnosis and explore potential treatment or management strategies.
By opting for this test at DNA Labs UAE, patients and their families can gain valuable insights into their genetic makeup, empowering them with information that could significantly impact their approach to managing juvenile ALS type 2.
The MATR3 Gene Amyotrophic Lateral Sclerosis Type 21 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the MATR3 gene, which are associated with the development of Amyotrophic Lateral Sclerosis (ALS) type 21. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to muscle weakness and, eventually, severe physical disability.
The test is particularly crucial for individuals with a family history of ALS or symptoms indicative of the disease, as identifying the genetic mutation can help in understanding the risk, potential progression, and possible familial implications of the condition. Conducted at DNA Labs UAE, a leading facility in genetic testing and diagnostics, the test ensures accuracy and confidentiality in handling patient samples.
The cost of the MATR3 Gene Amyotrophic Lateral Sclerosis Type 21 Genetic Test is 4400 AED. This investment covers the genetic analysis and the expertise required to interpret the results accurately. Given the complexity and the specialized nature of the test, the cost reflects the comprehensive analysis and detailed report provided to the patient, which can be instrumental in planning for treatment and management of the condition.
It's important for patients considering this test to consult with a healthcare provider or a genetic counselor to fully understand the implications of the results and to ensure that it is the right step in their diagnostic journey.
The SETX Gene Amyotrophic Lateral Sclerosis Type 4 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the SETX gene, which are associated with Amyotrophic Lateral Sclerosis (ALS) Type 4. ALS Type 4 is a rare hereditary form of the disease characterized by a slower progression compared to other types of ALS. The test plays a crucial role in early diagnosis, enabling targeted interventions and informed family planning decisions. Priced at 4400 AED, this genetic test involves analyzing the patient's DNA to detect specific genetic alterations in the SETX gene, providing valuable insights into the patient's condition and risk factors. DNA Labs UAE, known for its state-of-the-art facilities and expert genetic counseling, ensures a comprehensive support system for individuals undergoing this test.
The FUS Gene Amyotrophic Lateral Sclerosis Type 6 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the FUS gene, which are associated with the development of Amyotrophic Lateral Sclerosis (ALS) type 6. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to muscle weakness and, eventually, severe physical disability. The FUS gene plays a critical role in the functioning of neurons, and mutations in this gene can lead to the familial form of ALS, which accounts for a small percentage of ALS cases.
This test is particularly important for individuals with a family history of ALS or those who have been diagnosed with ALS and are seeking a genetic explanation for their condition. By identifying the presence of FUS gene mutations, the test can provide crucial information for the diagnosis, prognosis, and potential treatment options for patients and their families. It can also aid in genetic counseling for family members who may be at risk.
The cost of the FUS Gene Amyotrophic Lateral Sclerosis Type 6 Genetic Test at DNA Labs UAE is 4400 AED. The test is conducted using a sample of the patient's blood or saliva, which is then analyzed in the laboratory for the presence of genetic mutations in the FUS gene. The results of this test can have significant implications for the management and understanding of ALS, making it a valuable tool in the fight against this challenging condition.
The VAPB Gene Amyotrophic Lateral Sclerosis type 8 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the VAPB gene, which have been associated with a rare form of Amyotrophic Lateral Sclerosis (ALS), also known as ALS type 8. This condition is a progressive neurodegenerative disorder that affects nerve cells in the brain and the spinal cord, leading to muscle weakness and, eventually, severe physical disability.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis. By examining a patient's DNA sample, usually obtained through a blood draw, the test can pinpoint specific genetic alterations in the VAPB gene that are indicative of ALS type 8. This information is crucial for early diagnosis, allowing for better management of the condition and counseling for affected individuals and their families.
The cost of the VAPB Gene Amyotrophic Lateral Sclerosis type 8 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full analysis and a comprehensive report that details the findings. Given the complexity of genetic testing and the specialized technology required, the cost reflects the extensive resources involved in providing accurate and reliable results.
The ANG Gene Amyotrophic Lateral Sclerosis Type 9 Genetic Test is a specialized diagnostic tool used to identify mutations in the ANG gene, which are linked to the development of Amyotrophic Lateral Sclerosis (ALS) type 9. ALS, also known as Lou Gehrig's disease, is a progressive neurodegenerative disorder that affects nerve cells in the brain and spinal cord, leading to muscle weakness and, eventually, severe physical disability. The test is particularly valuable for individuals with a family history of ALS or those showing symptoms of the disease, as it can provide crucial information for early diagnosis and management.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific mutations in the ANG gene. These mutations can indicate a person's susceptibility to developing ALS type 9, allowing for early interventions and informed decisions regarding health and lifestyle.
The cost of the ANG Gene Amyotrophic Lateral Sclerosis Type 9 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of the information it provides for affected individuals and their families cannot be understated. It opens the door to genetic counseling, personalized treatment plans, and, in some cases, participation in clinical trials for novel therapies, significantly impacting the quality of life and disease management for those with or at risk of ALS type 9.
The C9orf72 gene test for Amyotrophic Lateral Sclerosis (ALS) with Frontotemporal Dementia (FTD) is a specialized genetic test available at DNA Labs UAE, designed to identify expansions in the C9orf72 gene, which are known to be the most common genetic cause of both familial ALS and FTD. This test is crucial for individuals with a family history of these conditions or those exhibiting symptoms, as it aids in the accurate diagnosis and understanding of their risk of developing these neurodegenerative diseases. The test is performed with a high degree of accuracy and confidentiality, ensuring patients receive comprehensive support and information. The cost of the C9orf72 gene test at DNA Labs UAE is 4400 AED, reflecting the sophisticated technology and expertise required to conduct this analysis.
The SS18L1 gene has been implicated in a range of neurological conditions, including Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control. The genetic test focusing on the SS18L1 gene's involvement in ALS, particularly in relation to the CREST syndrome - a complex disorder that can include calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia - provides crucial insights for individuals with a family history of ALS or related symptoms.
DNA Labs UAE offers a specialized genetic test targeting the SS18L1 gene to identify mutations that may contribute to the development of ALS and its overlap with CREST-related symptoms. This test is essential for patients seeking a comprehensive understanding of their genetic predisposition to ALS and CREST syndrome, allowing for early intervention, personalized treatment plans, and informed family planning.
The cost of this comprehensive genetic test is 4400 AED. Conducted at DNA Labs UAE, the test involves a simple procedure but offers profound insights into the patient's genetic makeup, potentially guiding crucial health decisions and lifestyle adjustments to manage or mitigate the risk of ALS and related conditions.
The NEFH gene, known for its role in encoding the heavy neurofilament protein, has been linked to susceptibility to Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease affecting nerve cells in the brain and the spinal cord. Genetic testing focused on the NEFH gene can provide crucial insights into an individual's risk of developing ALS, allowing for early intervention and personalized management strategies.
At DNA Labs UAE, a specialized test is available to assess the genetic variations in the NEFH gene that might increase susceptibility to ALS. The test, priced at 4400 AED, involves a comprehensive analysis of the NEFH gene to identify mutations that could indicate a higher risk of developing this debilitating condition. By opting for this genetic test, individuals can gain valuable information about their genetic predisposition to ALS, enabling them to make informed decisions about their health and future.
The VPS54 gene has been identified as a potential contributor to the development of Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disorder that affects nerve cells in the brain and spinal cord, leading to loss of muscle control. The VPS54-related genetic test is a specialized diagnostic tool designed to detect mutations in the VPS54 gene, which may indicate an increased risk or presence of ALS in individuals. This test is particularly useful for those with a family history of ALS or related symptoms, providing crucial information for early diagnosis and potential management of the condition.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the VPS54 gene test is performed with high precision and accuracy. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise involved in conducting the analysis. By opting for this test, individuals can gain valuable insights into their genetic predisposition towards ALS, enabling them to make informed decisions regarding their health and future care plans.
